Pacific Edge Limited logo

Capital Change Notice

Capital Change20 January 2021PEBHealthcare

Pacific Edge Limited
Capital Change Notice



2004256 | 5370298v2



Section 1: Issuer information

Name of issuer Pacific Edge Limited

NZX ticker code PEB

Class of financial product Ordinary shares

ISIN (If unknown, check on NZX website) NZPEBE0002S1

Currency NZ$

Section 2: Capital change details

Number issued/acquired/redeemed A total of 833,331 ordinary shares,

made up as follows:

(1) 30,000 ordinary shares

(2) 100,000 ordinary shares

(3) 166,666 ordinary shares

(4) 333,333 ordinary shares

(5) 20,000 ordinary shares

(6) 50,000 ordinary shares

(7) 100,000 ordinary shares

(8) 16,666 ordinary shares

(9) 16,666 ordinary shares

Nominal value (if any) Not applicable

Issue/acquisition/redemption price per security (1) $0.60 per share

(2) $0.51 per share

(3) $0.23 per share

(4) $0.69 per share

(5) $0.48 per share

(6) $0.69 per share

(7) $0.51 per share

(8) $0.23 per share

(9) $0.23 per share

Nature of the payment (for example, cash or other

consideration)

Cash

Amount paid up (if not in full) Paid in full

Percentage of total class of Financial Products

issued/acquired/redeemed/ (calculated on the number of

Financial Products of the Class, excluding any Treasury

Stock, in existence)

0.115%

For an issue of Convertible Financial Products or Options,

the principal terms of Conversion (for example the

Conversion price and Conversion date and the ranking of

the Financial Product in relation to other Classes of

Financial Product) or the Option (for example, the exercise

price and exercise date)

Not applicable




Reason for issue/acquisition/redemption and

specific authority for

issue/acquisition/redemption/ (the reason for

change must be identified here)

(1) Issued on exercise of 30,000 options at the

exercise price under the relevant option agreement

(2) Issued on exercise of 100,000 options at the

exercise price under the relevant option agreement

(3) Issued on exercise of 166,666 options at the

exercise price under the relevant option agreement

(4) Issued on exercise of 333,333 options at the

exercise price under the relevant option agreement

(5) Issued on exercise of 20,000 options at the

exercise price under the relevant option agreement

(6) Issued on exercise of 50,000 options at the

exercise price under the relevant option agreement

(7) Issued on exercise of 100,000 options at the

exercise price under the relevant option agreement

(8) Issued on exercise of 16,666 options at the

exercise price under the relevant option agreement

(9) Issued on exercise of 16,666 options at the

exercise price under the relevant option agreement

Total number of Financial Products of the

Class after the

issue/acquisition/redemption/Conversion

(excluding Treasury Stock) and the total

number of Financial Products of the Class

held as Treasury Stock after the

issue/acquisition/redemption.

726,910,681


In the case of an acquisition of shares,

whether those shares are to be held as

treasury stock

Not applicable

Specific authority for the issue, acquisition, or

redemption, including a reference to the rule

pursuant to which the issue, acquisition, or

redemption is made

Issue 1 – 6 by Directors resolution dated 14 January

2021 approving issue under listing rule 4.9.1(b)


Issue 7 – 9 by Directors resolution dated 18 January

2021 approving issue under listing rule 4.9.1(b)



Terms or details of the issue, acquisition, or

redemption (for example: restrictions, escrow

arrangements)

New ordinary shares which rank equally with all

other fully paid ordinary shares

Date of issue/acquisition/redemption Shares were issued on the dates below


Allocation Date

1 – 15 January 2021

2 – 6 18 January 2021

7 – 9 20 January 2021

Pacific Edge Limited
Capital Change Notice



2004256 | 5370298v2

Section 3: Authority for this announcement and contact person

Name of person authorised to make this

announcement

Grant Gibson (CFO, Pacific Edge)

Contact person for this announcement Grant Gibson (CFO, Pacific Edge)

Contact phone number +64 3 479 5800

Contact email address grant.gibson@pelnz.com

Date of release through MAP 21 January 2021

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • PHL — Promisia Healthcare Limited: Capital Change Notice
    2021-03-24

    Capital Change Notice 12786918_1 Section 1: Issuer information Name of issuer Promisia Healthcare Limited (PHL) NZX ticker code PHL Class of financial product Ordinary shares ISIN NZPRPE0001S5 Currency New Zealand Dollars Section 2: Capital change details Number i…”

  • PHL — Promisia Healthcare Limited: Allotment of New Equity (Amended)
    2021-03-31

    Capital Change Notice 12821817_1 Section 1: Issuer information Name of issuer Promisia Healthcare Limited (PHL) NZX ticker code PHL Class of financial product Ordinary shares ISIN NZPRPE0001S5 Currency New Zealand Dollars Section 2: Capital change details Number i…”

  • PHL — Promisia Healthcare Limited: Allotment of New Equity
    2021-03-31

    Capital Change Notice 12821817_1 Section 1: Issuer information Name of issuer Promisia Healthcare Limited (PHL) NZX ticker code PHL Class of financial product Ordinary shares ISIN NZPRPE0001S5 Currency New Zealand Dollars Section 2: Capital change details Number i…”